Physician profile
Sunil Thacker
NPI 1053455345
$48,787.33
in general payments reported to CMS, 2019-2025
12 companies · $2,022 in 2025
The $2,022 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,420 · 2020: $35K · 2021: $969 · 2022: $2,208 · 2023: $459 · 2024: $540 · 2025: $2,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,915 · Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,915.07 |
| Food and Beverage | $1,105.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $41,143.93 | 2019-2020 | |
| Arthrex, INC. | $4,048.51 | 2019-2025 | |
| Seapearl East, INC | $2,336.55 | 2020-2025 | |
| Maxx Health INC | $844.03 | 2021 | |
| Depuy Synthes Sales INC. | $182.92 | 2019-2021 | |
| Miach Orthopaedics, INC. | $114.26 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $31.68 | 2025 | |
| Si-Bone, INC. | $27.06 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.01 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $14.04 | 2023 | Iovera, Zilretta, Exparel |
| Ferring Pharmaceuticals INC. | $13.84 | 2023 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Thacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.